Teva’s Copaxone patent problems continue

A board to discuss the Multiple Sclerosis modifying drug Copaxone
Post Reply
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Teva’s Copaxone patent problems continue

Post by MSUK » Mon Sep 01, 2014 12:02 am

Teva Pharmaceuticals Industries Ltd is in trouble again for its multiple sclerosis (MS) injectable drug-Copaxone, as other drug manufacturers seek to launch their own generic versions of the drug. Teva has been fighting patent battles to ward off other pharmaceutical companies from making generic copies of Copaxone.

Copaxone makes up one-fifth of the company’s sales, but it is expected to lose 50% of its revenues by 2016, after its generic copies are launched. To deal with this impending threat, Teva introduced an improved version of the drug, with a higher dosage. But despite the introduction of the new Copaxone 40mg, troubles continue to pile up for the company...... Read More -

Family Elder
Posts: 725
Joined: Tue May 14, 2013 2:00 pm

Re: Teva’s Copaxone patent problems continue

Post by THX1138 » Mon Sep 01, 2014 8:37 am

This will be a big blow to the company, as Copaxone is a crucial part of its sales. The Copaxone 40mg has already earned $411.5 million in revenues since its launch, however cheaper versions of the drug will deeply reduce its sales. Copaxone 40mg is priced at $60,500 per year, only $1000 less than Copaxone 20mg. Any cheaper versions of the drug are expected to do well.
:cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry: :cry:

Post Reply
  • Similar Topics
    Last post